<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/39A7BF7E-30F0-4EE2-8DB6-F7F639E87F1B"><gtr:id>39A7BF7E-30F0-4EE2-8DB6-F7F639E87F1B</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Meehan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_U127574433"><gtr:id>D5ECC507-14CE-4FBD-B95F-4ECA3E95049E</gtr:id><gtr:title>Epigenetics and Development</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_U127574433</gtr:grantReference><gtr:abstractText>Our DNA encodes the central core of genetic information of the cell, which is dictated by the order of the four bases: adenine, cytosine, guanine and thymine. Throughout development, there are distinct patterns of gene expression at different stages and cell types. Consequently, there must be a level of information apart from the primary DNA sequence that specifies the selective use of genetic information in different cells. A modified base, 5-methylcytosine (5mC), is found on DNA that exhibits distinct patterns between different cells. The presence of 5mC at genes can result in gene silencing.||We are trying to understand the mechanisms by which the enzymes that introduce methylation onto DNA cause gene silencing during animal development and why the modified base, 5mC, is necessary for cellular stability? The importance of 5mC is underlined by the observation that many cancers and rare human diseases have altered patterns of DNA methylation compared to normal cells.||To understand the role of DNA methylating enzymes in cells, we produce cells lacking these enzymes and characterise what happens at the molecular level. In this way, we hope to understand the role of this important process in development and disease.</gtr:abstractText><gtr:technicalSummary>Epigenetics describes the variation of gene expression that is not due to changes in the DNA sequence. It is an important process during animal early development for setting up and maintaining stable patterns of gene transcription in adult tissues. In essence it describes how modification of chromatin or DNA regulates a genes activity.||Our main interest is determining the interplay between chromatin and DNA based silencing mechanisms in maintaining gene silencing during early animal development? We have made some exciting discoveries establishing the importance of epigenetic regulators in determining the onset of transcription during early development in amphibians, and how mis-regulation of these processes may lead to apoptosis and subsequent alterations in cellular identity and development.||The maintenance cytosine methyltransferase, xDnmt1, is responsible for maintaining high levels of DNA methylation in development. We have shown that it also acts as a direct transcription repressor protein, independently of its catalytic function, in early embryos. In addition we have identified a potential pathway though which loss of xDnmt1 function results in direct activation of a cell death pathway.||We believe our findings have important implications for the molecular basis of diverse human diseases in which epigenetic regulation is altered and potentially an understanding of the nature of cellular potency (stem cells). Our work may also contribute to the development of safe health care applications such as small molecule inhibitors of Dnmt1 function.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2694160</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Innovative Medicines Initiative (IMI)</gtr:department><gtr:description>MARCAR (Mechanism-driven development of early biomarkers and molecular tumor classification for non-genotoxic carcinogenesis)</gtr:description><gtr:id>C7D713FD-59ED-485E-9D01-EA023FD984C0</gtr:id><gtr:impact>I am part of a consortium (MARCAR) that after a competitive application process, has been selected by the Innovative Medicines Initiative (IMI) to negotiate a 3-5 year program of work that aims to improve the predictivity of safety evaluation in non-genotoxic carcinogenesis. We proposed a research program that includes epigenetic analysis of novel model systems and unique archived material of industrial partners (EFPIA). If the application proceeds successfully, there will be matching (in-kind) funds from EFPIA members. An ultimate aim of the research program is to identify new biomarkers for non-genotoxic carcinogenesis in liver.</gtr:impact><gtr:outcomeId>6B28CEEFDA1-1</gtr:outcomeId><gtr:partnerContribution>I am part of a consortium (MARCAR) that after a competitive application process, has been selected by the Innovative Medicines Initiative (IMI) to negotiate a 3-5 year program of work that aims to improve the predictivity of safety evaluation in non-genotoxic carcinogenesis. We proposed a research program that includes epigenetic analysis of novel model systems and unique archived material of industrial partners (EFPIA). If the application proceeds successfully, there will be matching (in-kind) funds from EFPIA members. An ultimate aim of the research program is to identify new biomarkers for non-genotoxic carcinogenesis in liver.European networking, the application of epigenetics to toxicology testing. New interaction with NHI (US) funded agencies and colleagues. The successful application for Funding from IMI (EU) to commence in January 2009.</gtr:partnerContribution><gtr:piContribution>I am part of a consortium (MARCAR) that after a competitive application process, has been selected by the Innovative Medicines Initiative (IMI) to negotiate a 3-5 year program of work that aims to improve the predictivity of safety evaluation in non-genotoxic carcinogenesis. We proposed a research program that includes epigenetic analysis of novel model systems and unique archived material of industrial partners (EFPIA). If the application proceeds successfully, there will be matching (in-kind) funds from EFPIA members. An ultimate aim of the research program is to identify new biomarkers for non-genotoxic carcinogenesis in liver.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>13th European ISSX Meeting Galsgow 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8BAC8E77-4D9B-47DE-B9C1-C02A43289D2D</gtr:id><gtr:impact>I acted as a local organier:
ISSX advances research and education on the interplay
of living systems with medicines and chemicals for the benefit of society worldwide.

 
Objectives of the Society

 Foster and encourage inter-disciplinary, innovative science relating to the disposition, metabolism and biological effects of drugs and other xenobiotics

 Facilitate the association of scientists from all geographic regions in this field and related disciplines

 Disseminate and discuss the results of research and related matters of interest

 Promote education and training in this field</gtr:impact><gtr:outcomeId>56d9853fb57942.86841685</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.issx.org/?page=Past</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FEBS Workshop Denmark</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>806E233A-BF56-4525-B2CC-F514BDDE7F00</gtr:id><gtr:impact>I presented two lectures; one present trends in Epigenetics Research and a second on my own research programs.

My talks stimulated much debate and questions.</gtr:impact><gtr:outcomeId>thSpGhMNtgv</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Epigenetics in dialogue with THE GENOME</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E68B70B1-E558-4022-8477-060624987E70</gtr:id><gtr:impact>The epigenetics field encompasses diverse opinions - even the definition of the word is controversial. How much our own make-up is genetic and what proportion of it is epigenetically determined is also hotly debated. Moreover, the ability of apparent epigenetic phenotypes (epi-alleles) to be propagated through the germline to the next generation (transgenerational epigenetic inheritance) remains contentious. These conceptual arguments take place against a background of increasing research activity - epigenetics is one of the most active areas in biomedical research. Large-scale mapping projects, for example, provide increasingly detailed descriptions of the &amp;quot;epigenome&amp;quot;, raising as yet incompletely answered questions about the biological role of these chemical marks. Meanwhile there is growing interest in the therapeutic potential of &amp;quot;epigenetic drugs&amp;quot; that can modulate the epigenetic landscape. Genes encoding proteins that read, write or erase epigenetic marks are often mutated in cancer or in neurological disease. The purpose of this meeting is to provide a forum where the breadth of biological phenomena that impinge on epigenetics can be presented by leading international figures in epigenetics research. The selected speakers reflects our wish that alternative views will be aired and constructively discussed. Our intention is that this will be seen as a landmark meeting, contributing clarity to one of the most exciting areas of contemporary biomedical research.</gtr:impact><gtr:outcomeId>56d98e679e5135.68669388</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://epiburgh.bio.ed.ac.uk/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>	&quot;DNA methylation and demethylation&quot; Jacques Monod Conf?rence</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A968BB22-D96B-4F8B-A9B4-A56AE70B7931</gtr:id><gtr:impact>Formed new collaborations

Formed new collaborations, got invited to contribute reviews on my research area</gtr:impact><gtr:outcomeId>542e916b77f0e6.79486019</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cnrs.fr/insb/cjm/cjmbilan_e.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Annual Epigenetics Discovery Congress, 8-9 Sep, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E6609879-DE10-4A09-9DD2-DED49F01E67A</gtr:id><gtr:impact>Title: Epigenetic profiling and environmental challenge

Highlights:
- 5mC/5hmC profiling tracks environmental exposure in model systems
- Allows identification of potential epigenetic predictors of end point pathologies
- Studying the effects of environmental triggers on the epigenome will enable identification of novel biomarkers.</gtr:impact><gtr:outcomeId>58c67bdbcf4e25.35562022</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mnmconferences.com/EventPDF/Postshow_%202nd%20Annual%20Epigenetics%20Discovery%20Congress.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium on Assessing Adverse Epigenetic Effects of Drugs and Chemicals</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4BE36CD7-89FF-41A1-9D81-0A9BD8AC005A</gtr:id><gtr:impact>New technological advances have led to recent and rapid progress in the characterization and mapping of epigenetic changes. However, there are significant knowledge gaps in understanding the relevance of such changes for toxicological safety assessment that requires further investigation with respect to the science, including potential model systems, endpoints and the most relevant techniques that could be employed.

Epigenetics, which represents mechanisms that control gene expression in a potentially heritable way without modification of the DNA sequence, is a rapidly developing area of research with relevance to stem cell differentiation, developmental processes, cancer and other diseases. Several mechanisms, including DNA methylation, histone modifications, and regulatory noncoding RNAs, appear to influence gene expression in an epigenetic manner. Epigenetic alterations can be induced by exposure to environmental chemicals or as side effects of drugs and thus have implications for human health. In addition, drugs that target specific epigenetic mechanisms are being developed to treat human disease, including several that have been approved for use.

A maniscript arose out of the meeting and new collaborations were pursued.</gtr:impact><gtr:outcomeId>542e98f7ee0390.39330638</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.hesiglobal.org/i4a/pages/index.cfm?pageID=3639</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CHI's 7th Annual Bioprocessing Summit - Optimizing Cell Culture Technology Boston, MA, USA.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CCC216D0-8592-4BBB-BA6C-14E6734EE2BC</gtr:id><gtr:impact>Talk Title: 5-Hydroxymethylcytosine (5hmC) Barcoding and Cell Identity

Abstract: An assumption underlying the use of cultured cells is that they retain and mimic the molecular characteristics of the tissue from which they were derived or conform to an industry standard that enables their reproducible use in bio-manufacturing. By studying the establishment of fibroblasts and T-cells in culture, we found that adaptation resulted in a rapid and comprehensive re-programming of the transcriptome and epigenome, indicative of an altered cell state. Re-programming involved almost complete loss of 5hmC in cultured cells. Restoration of 5hmC profiles is indicative of restoration of cell identity.

Presented our work on Epigenetics and cell identity to an mainly industrial audience:

About the Event

The Bioprocessing Summit brings together international leaders to discuss today's bioprocess issues from cell line selection to bioproduction. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer along the lively and cosmopolitan harbor waterfront. Each year, the international bioprocessing community comes together at the Summit to share practical solutions for today's bioprocess challenges with researchers from around the world. Spanning five days, the 2016 meeting includes 16 conference programs, 9 training seminars, and 10 short courses.</gtr:impact><gtr:outcomeId>58c679f3b8e670.11593044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.bioprocessingsummit.com/cell-culture/15/#2</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 20th International Symposium on Microsomes and Drug Oxidations,</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A280FC0E-E557-48ED-99E9-5E2E96E97BE9</gtr:id><gtr:impact>The symposium is a unique opportunity to meet top ranking professionals from basic science, drug development and clinical pharmacology, and for interdisciplinary communication between academia and industry. An exciting program was presented, featuring keynote and plenary lectures, symposia and poster sessions.

My plenary lecture ( Epigenetic mechanisms in development and disease) was widely discussed and desiminated.</gtr:impact><gtr:outcomeId>542e9aecbe4f11.46179563</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mdo2014.de/Organizing-Committees.416.0.html</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Epigenetics in Carcinogenesis 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CBC85B8E-9D5B-4196-BEE2-1FBD5F43A2FA</gtr:id><gtr:impact>Presentation of our our on the theme of 'Environmental exposure and Epigenetics'.</gtr:impact><gtr:outcomeId>56d98420aea606.23929591</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.dgpt2015.de/topics.html#filter2</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>44th Annual Meeting of European Environmental Mutagenesis and Genomics Soc</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3C71C384-C9B1-4C42-9FF9-8F22125E4E04</gtr:id><gtr:impact>Presented a talk on Epigenetics and Toxicity


The EEMS is a scientific society that encourages the study of mutagens and substances of related biological activity in the human environment, particularly as these mutagens may be of concern to public health, and to engage in and sponsor research, study and dissemination of information relating to the foregoing.&amp;quot;</gtr:impact><gtr:outcomeId>56d9875181cb27.18312914</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.eemgs.eu/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5hmC Workshop Biochem Soc</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83EBB34A-45F2-44E3-B18C-2AB9D62BB454</gtr:id><gtr:impact>The New Epigenetic Mark: 5-Hydroxymethylcytosine - What is its Function?
13 June 2013: Cancer Research UK Cambridge Institute, UK
Title: Knowing me, Knowing you. Ahaaaa! 5hmC and the Epigenetics of identity


I made a you tubre presentation to explain the topic.

http://www.youtube.com/watch?v=0EXzIOw4hNg</gtr:impact><gtr:outcomeId>oDEGjQAnynd</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.biochemistry.org/tabid/379/MeetingNo/HT006/view/Programme/default.aspx</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rome: Epigenetics and Chemical Safety</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8BA43D78-E6B6-4650-BD21-8771BF527771</gtr:id><gtr:impact>The workshop addressed the following aspects:

 examine scientific and technological approaches to identify and quantify epigenetic effects of chemicals and to assess their potential effects on human health and ecology.

 consider the strengths and weaknesses and the costs and benefits of looking at epigenetic effects of chemicals by using new approaches and technologies.

In particular the workshop addressed the following points:

 Definition of epigenetic changes and effects in the context of (eco-) toxicology.
 What are the consequences of epigenetic changes induced by exogenous substances on human and environmental health?
 Is the current way of assessing the safety of chemicals able to detect adverse effects related to epigenetic changes?
 Case studies: implications of epigenetics in adverse effects in Humans, in animal models and ecotoxicology


WE produced a report.
http://www.ecetoc.org/index.php?mact=MCSoap,cntnt01,details,0&amp;amp;cntnt01by_category=22&amp;amp;cntnt01order_by=date%20Desc&amp;amp;cntnt01template=display_list_v2&amp;amp;cntnt01display_template=display_details_v2&amp;amp;cntnt01document_id=6329&amp;amp;cntnt01returnid=59

WR 23 : ECETOC WR 23 - Epigenetics and Chemical Safety | 18 June 2012

Epigenetics is a rapidly developing and expanding biological science which will change our perception of cell biology in a profound way. In order to increase our knowledge of how epigenetics could have an impact in (eco)toxicology, a solid understanding of the biology and variation of the epigenome is essential to better assess concerns about possible adverse health effects related to epigenetic changes.</gtr:impact><gtr:outcomeId>sFykiEPQHKS</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.ecetoc.org/index.php?mact=XtendedCalendar,cntnt01,details,0&amp;cntnt01documentid=41&amp;cntnt01returnid=108</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 50th Congress of the European Societies of Toxicology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BF1E6815-F055-42A5-AFCB-5BDFDBFE9639</gtr:id><gtr:impact>The Conference aim was to &amp;quot;Advance Science for Human and Environmental Health. There was a mix of plenary and keynote lectures, symposia, workshops and a full continuing education programme.

Futher invitations to participate in future meetings</gtr:impact><gtr:outcomeId>542e9be9144ca3.59033145</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.eurotox2014.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on Epigeneticsand Chemical Safety</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>609C6EA9-A8AD-43B6-8353-BB065A16E08C</gtr:id><gtr:impact>My talk on new methods for assessing epigentic perturnations was well received and stimulated much debate and questions.

We produced a report that was published in 2012 that was entitled 'Epigenetics and Chemical Safety'.</gtr:impact><gtr:outcomeId>Z7PT8DuX9uq</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bio-IT World and Cambridge Healthtech Institute's Inaugural Clinical Epigenetics workshop</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE203477-37AC-433F-B6BF-57D37D499E82</gtr:id><gtr:impact>ecently, and fueled in part by the application of high-throughput sequencing technologies, our understanding of the disease epigenome has expanded, with the inclusion of numerous mutated genes involved in epigenetic regulation, and epimutations directly involved in producing aberrant gene expression. Epigenetic dysregulation is now a hallmark of several complex pathologies, including cancer, metabolic disorders, cardiovascular and neurological diseases, where disease-specific epigenetic signatures are now being utilized clinically for prognostics, diagnostics as well as disease-specific targeted therapy. This event is designed to unite clinicians and researchers using high-throughput technologies to explore regulatory layers above the genome, ultimately for clinical utility.

Old links renewed, new collaborations formed.</gtr:impact><gtr:outcomeId>542e99c3e22311.16128211</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.clinicalgenomicsinformatics.com/Clinical-Epigenetics/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2016 Plenary Speaker SOT Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment Tysons Corner, Virginia, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>41B84179-AB08-475C-8C02-6766D2CFFBFA</gtr:id><gtr:impact>Title: The Epigenome As a Mediator of Environmental Effects on Development and Implications in Disease Development


Talk will discuss effects of environmental exposures on the epigenome and their implications on human and public health outcomes. Additionally, the presentation will incorporate the epigenetic outcomes of exposures as molecular initiating events and the role of the epigenome in directing key event relationships in adverse outcome pathways. 
Summary:
Epigenetic profiles reflect cellular identity

These profiles can act as a 'proxy' for changes that occur in development, disease state (treatment and remission) or environmental exposure.

Contribute to new pathway identification that operates in developmental, disease and drug metabolism contexts

Use in risk assessment - under advisement</gtr:impact><gtr:outcomeId>58c68093026c17.93529266</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.toxicology.org/events/shm/cct/Toxicoepigenetics.asp</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Epigenetic Landscape Global Nuclear Positioning Tools</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/K01384X/1</gtr:fundingRef><gtr:id>6581D77D-FDC7-4298-8C29-89609206699C</gtr:id><gtr:outcomeId>PtdeHMcSuBD</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Breakthrough Breast Cancer Research Unit</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Breakthrough Breast Cancer</gtr:fundingOrg><gtr:id>A53A3BDB-F531-4D63-8CFF-3C6D17AA3017</gtr:id><gtr:outcomeId>F419CF8068D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mechanisms underlying the transmission of programming effects</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K018310/1</gtr:fundingRef><gtr:id>8EFBBDBA-6CCF-4DB8-A727-A0E548248332</gtr:id><gtr:outcomeId>EYPpS8mZzEx</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>530000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Responsive Mode Project Grant: Vitamin C programming of self-renewal and pluripotency in rat embryonic stem cells</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M023397/1	</gtr:fundingRef><gtr:id>290CC50B-EB9A-4F62-88C9-B2A2C18D1244</gtr:id><gtr:outcomeId>56d97d8e34d256.62374949</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Hydroxy-Sensitive Cut Counting (HSCC); simultaneous, genome-wide mapping of 5-methylcytosine and 5-hydroxymethylcytosine in mammals</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J021032/1</gtr:fundingRef><gtr:id>A6F9B4CB-CB2B-4D83-8E24-7399A79CB132</gtr:id><gtr:outcomeId>G3y6AcXYYs8</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/Medical Research Foundation PsySTAR PhD studentship: The role of DNA methylation in neural development.</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DB2D1369-9ED6-4D76-BAFF-769C823C6496</gtr:id><gtr:outcomeId>56d97f6b8f8dd5.83904187</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>346689</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European Chemical Industry Council (CEFIC)</gtr:department><gtr:description>Long Range Initiative (LRI) -THE EUROPEAN CHEMICAL INDUSTRY COUNCIL -Cefic</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>International Council of Chemical Associations (ICCA)</gtr:fundingOrg><gtr:fundingRef>RB0329</gtr:fundingRef><gtr:id>E6CDFF58-B9E8-4A45-A7E3-05A751B2690B</gtr:id><gtr:outcomeId>542e7aacc1acb2.64070986</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Epigenetics and Chemical Safety ; Rome</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>96398A99-9059-4984-BC78-B9BE1C45808F</gtr:id><gtr:outcomeId>K3vmtPQW7L4</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.ecetoc.org/eventsmanager/20/258/Epigenetics-and-Chemical-Safety/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>The Role of Epigenetics in Reproductive Toxicity</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6EA3BEC6-A3BB-463C-9F90-AD2F44D5F7DE</gtr:id><gtr:impact>AIM
The workshop has the following four objectives:
1. Define epigenetics and understand its potential value for reproductive toxicology

2. Understand the relationship between epigenetic change and adverse end points

3. Develop a roadmap to for the practical use of epigenetic studies in regulatory applications

4. Generate a prioritised research agenda

A Workshop Report will be developed and it is anticipated to publish the workshop findings in an open access, peer-reviewed journal.</gtr:impact><gtr:outcomeId>56d98846d90fe8.25177584</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.ecetoc.org/index.php?mact=MCSoap,cntnt01,details,0&amp;cntnt01by_category=22&amp;cntnt01order_by=date%20Desc&amp;cntnt01template=display_list_v2&amp;cntnt01display_template=display_details_v2&amp;cntnt01document_id=6329&amp;cntnt01returnid=59</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>EpiGeneSys</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>22FA4A9E-7841-4C5B-87E5-866F0005F3E2</gtr:id><gtr:outcomeId>tk9nyAVzmM6</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.epigenesys.eu/en/</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>16. Promoter DNA methylation couples genome-defense mechanisms to epigenetic reprogramming in the mouse germline (part 2)
(Submitter supplied) Mouse primordial germ cells (PGCs) erase global DNA methylation (5mC) as part of the comprehensive epigenetic reprogramming that occurs during PGC development. 5mC plays an important role in maintaining stable gene silencing and repression of transposable elements (TE) but it is not clear how the extensive loss of DNA methylation impacts on gene expression and TE repression in developing PGCs. Using a novel epigenetic disruption and recovery screen and genetic analyses, we identified a core set of germline-specific genes that are dependent exclusively on promoter DNA methylation for initiation and maintenance of developmental silencing. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6885 2 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE38nnn/GSE38306/
Series Accession: GSE38306 ID: 200038306

17. Promoter DNA methylation couples genome-defense mechanisms to epigenetic reprogramming in the mouse germline (part 1)
(Submitter supplied) Mouse primordial germ cells (PGCs) erase global DNA methylation (5mC) as part of the comprehensive epigenetic reprogramming that occurs during PGC development. 5mC plays an important role in maintaining stable gene silencing and repression of transposable elements (TE) but it is not clear how the extensive loss of DNA methylation impacts on gene expression and TE repression in developing PGCs. Using a novel epigenetic disruption and recovery screen and genetic analyses, we identified a core set of germline-specific genes that are dependent exclusively on promoter DNA methylation for initiation and maintenance of developmental silencing. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 3 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE38nnn/GSE38305/
Series Accession: GSE38305 ID: 200038305

18. Gene expression in 16 dpp Tex19.1-/- mouse testes
(Submitter supplied) Microarray experiment to identify changes in gene expression in 16 day post partum prepubertal Tex19.1-/- mouse testes. Tex19.1 is expressed in germ cells in testes. Tex19.1-/- mice have spermatogenic defects and errors in progression through meiosis. Data provides insight into the changes in gene expression in developing testes at the time when meiotic defects first start to become apparent.
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 8 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE30nnn/GSE30461/
Series Accession: GSE30461 ID: 200030461

19. Hydroxymethyl DNA-IP of genomic DNA for many different normal human tissues
(Submitter supplied) 5-hmC is a novel epigenetic mark derived from oxidation of methylcytosine. We profile this mark in several normal human tissues 5-hmC patterns are highly tissue specific and enriched in the body of transcribed genes 5-hmC patterns are highly tissue specific and enriched in the body of transcribed genes
Organism: Homo sapiens
Type: Methylation profiling by genome tiling array
Platform: GPL14788 14 Samples
FTP download: GEO (PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE33nnn/GSE33219/
Series Accession: GSE33219 ID: 200033219

20. Analysis of Promoter Methylation in Breast Cancer
(Submitter supplied) Promoter methylation was assayed in a number of breast cancer and control normal samples along with the effects of 5'-aza-2'-deoxycytidine on breast cancer cell line transcriptomes. Aberrant promoter hypermethylation is frequently observed in cancer. The potential for this to contribute to tumour development depends on whether the genes affected are repressed because of their methylation. Many aberrantly methylated genes play important roles in development and are bivalently marked in ES cells suggesting that their aberrant methylation may reflect developmental processes. more...
Organism: Homo sapiens
Type: Methylation profiling by array; Expression profiling by array
Platforms: GPL8490 GPL6947 107 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE26nnn/GSE26990/
Series Accession: GSE26990 ID: 200026990</gtr:description><gtr:id>F5592A7C-CEDC-4AC9-BCC3-B33F4C7E589E</gtr:id><gtr:impact>Avaialable for Meta analysis by other groups</gtr:impact><gtr:outcomeId>nRayeJAJWa7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data sets Part II</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/gds</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a technique to map athe newly modified base 5-hydroxymethylcytosine in geneomic DNA.</gtr:description><gtr:id>227F96B1-115D-46AA-B84C-1F688A5001E4</gtr:id><gtr:impact>3 high impact publications, with more to follow.</gtr:impact><gtr:outcomeId>Br9qjdjByQs</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>H-DIP</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://genomebiology.com/content/13/10/R93</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>1. Dynamic changes in liver 5-hydroxymethylcytosine profiles upon non-genotoxic carcinogen exposure [Replicated control vs. pb treated study]
(Submitter supplied) Dynamic changes in the mouse liver DNA methylome associated with short (1 day) and prolonged (7, 28 and 91 days) exposure to the rodent liver non-genotoxic carcinogen (NGC), phenobarbital (PB).
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL1261 39 Samples
FTP download: GEO (CEL) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE45nnn/GSE45465/
Series Accession: GSE45465 ID: 200045465

2. Gene expression in E18.5 Tex19.1-/- mouse placenta
(Submitter supplied) Microarray experiment to identify changes in gene expression in 18.5 day post coitum Tex19.1-/- mouse placenta. Tex19.1 is expressed in trophectoderm-derived cells in the placenta. Tex19.1-/- placentas are small and have defects in junctional zone and labyrinth layers of the placenta, Tex19.1-/- embryos exhibit intra-uterine growth retardation. Data provides insight into the changes in gene expression and cell composition in Tex19.1-/- placentas.
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 12 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE41nnn/GSE41823/
Series Accession: GSE41823 ID: 200041823

3. Reduced Representation Bisulfite Sequencing in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Methylation profiling by high throughput sequencing
Platform: GPL13112 2 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44760/, SRA SRP018930 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018930/
Series Accession: GSE44760 ID: 200044760

4. DNA methylation profiling by HELP-seq in Dnmt1+/+ mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Methylation profiling by high throughput sequencing
Platform: GPL9250 1 Sample
FTP download: GEO (BEDGRAPH) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44757/, SRA SRP018929 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018929/
Series Accession: GSE44757 ID: 200044757

5. mRNA-seq in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Expression profiling by high throughput sequencing
Platform: GPL13112 2 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44733/, SRA SRP018928 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018928/
Series Accession: GSE44733 ID: 200044733

6. Chip-seq for H3K27me3 and H3K4me3 in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Genome binding/occupancy profiling by high throughput sequencing
Platform: GPL11002 4 Samples
FTP download: GEO (BEDGRAPH) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44393/, SRA SRP018761 ftp://ftp-trace.ncbi.nlm.nih.gov/sra/sra-instant/reads/ByStudy/sra/SRP/SRP018/SRP018761/
Series Accession: GSE44393 ID: 200044393

7. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of polycomb-target genes
(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism: Mus musculus
Type: Expression profiling by array; Genome binding/occupancy profiling by genome tiling array; Methylation profiling by high throughput sequencing; Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing
6 related Platforms 35 Samples
FTP download: GEO (BEDGRAPH, PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44278/
Series Accession: GSE44278 ID: 200044278

8. Comparison of gene expression in Dnmt1+/+ and Dnmt1-/- MEFs
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6887 6 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44277/
Series Accession: GSE44277 ID: 200044277

9. Comparison of gene expression in Dnmt1+/+ MEFs treated with 5-aza-2'-deoxycytidine or vector control
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL6885 8 Samples
FTP download: GEO (TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44276/
Series Accession: GSE44276 ID: 200044276

10. Chip-chip for H3K27me3 and H3K4me3 in DNA methylation deficient mouse embryonic fibroblasts
(Submitter supplied) DNA methylation and the Polycomb Repression System are epigenetic mechanisms that play important roles in maintaining transcriptional repression. Recent evidence suggests that DNA methylation can attenuate the binding of Polycomb protein components to chromatin and thus plays a role in determining their genomic targeting. However, whether this role of DNA methylation is important in the context of transcriptional regulation is unclear. more...
Organism: Mus musculus
Type: Genome binding/occupancy profiling by genome tiling array
Platform: GPL16605 12 Samples
FTP download: GEO (PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE44nnn/GSE44149/
Series Accession: GSE44149 ID: 200044149

11. IP of 5-methylcytosine (5-mC) enriched DNA fragments from control and PB treated mouse livers (28 day)
(Submitter supplied) 5-mC is an epigenetic modification of the DNA base cytosine with roles in gene silencing events, imprinting and X inactivation. Phenobarbital (PB) is a well studied non-genotoxic carcinogen with roles in epigenetic perturbation. We profile 5mC in both control mouse livers as well as in the livers of 28 day PB treated mice. 5mC is largely found to reside in the bodies of active genes and promoter levels are perturbed upon PB induced gene activation events. more...
Organism: Mus musculus
Type: Methylation profiling by genome tiling array
Platform: GPL14890 10 Samples
FTP download: GEO (PAIR, TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40538/
Series Accession: GSE40538 ID: 200040538

12. IP of 5-hydroxymethylcytosine (5-hmC) enriched DNA fragments from control and PB treated mouse livers (28 day)
(Submitter supplied) 5-hmC is a novel epigenetic mark derived from oxidation of methylcytosine. Phenobarbital (PB) is a well studied non-genotoxic carcinogen with roles in epigenetic perturbation. We profile 5hmC in both control mouse livers as well as in the livers of 28 day PB treated mice. 5hmC is largely found to reside in the bodies of active genes and promoter levels are perturbed upon PB induced gene activation events. more...
Organism: Mus musculus
Type: Methylation profiling by genome tiling array
Platform: GPL14890 10 Samples
FTP download: GEO (PAIR, TXT) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40537/
Series Accession: GSE40537 ID: 200040537

13. IP of 5-hydroxymethylcytosine (5-hmC) and 5-methylcytosine (5-mC) enriched DNA fragments from control and PB treated mouse livers
(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism: Mus musculus
Type: Methylation profiling by genome tiling array; Expression profiling by array; Genome binding/occupancy profiling by high throughput sequencing
6 related Platforms 153 Samples
FTP download: GEO (BEDGRAPH, CEL, PAIR) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40540/
Series Accession: GSE40540 ID: 200040540

14. Dynamic changes in liver 5-hydroxymethylcytosine profiles upon non-genotoxic carcinogen exposure
(Submitter supplied) 29-32 days old male mice where either treated with Phenobarbital or untreated
Organism: Mus musculus
Type: Expression profiling by array
Platform: GPL1261 10 Samples
FTP download: GEO (CEL) ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE40nnn/GSE40773/
Series Accession: GSE40773 ID: 200040773

15. Promoter DNA methylation couples genome-defense mechanisms to epigenetic reprogramming in the mouse germline
(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism: Mus musculus
Type: Expression profiling by array
Platforms: GPL6885 GPL6887 5 Samples
FTP download: GEO ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE38nnn/GSE38307/
Series Accession: GSE38307 ID: 200038307</gtr:description><gtr:id>7A4FD821-4D8B-4223-BDB8-EAF900487C7A</gtr:id><gtr:impact>Available for Meta analysis by other groups</gtr:impact><gtr:outcomeId>CBjJoW1DEGb</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Data Sets Generated by work</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/gds</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Modification of DNA resulting in 5-methylcytosine (5 mC) or 5-hydroxymethylcytosine (5hmC) has been shown to influence the local chromatin environment and affect transcription. Although recent advances in next generation sequencing technology allow researchers to map epigenetic modifications across the genome, such experiments are often time-consuming and cost prohibitive. Here we present a rapid and cost effective method of generating genome wide DNA modification maps utilising commercially available semiconductor based technology (DNA immunoprecipitation semiconductor sequencing; &amp;quot;DIP-SC-seq&amp;quot;) on the Ion Proton sequencer. Focussing on the 5hmC mark we demonstrate, by directly comparing with alternative sequencing strategies, that this platform can successfully generate genome wide 5hmC patterns from as little as 500 ng of genomic DNA in less than 4 days. Such a method can therefore facilitate the rapid generation of multiple genome wide epigenetic datasets</gtr:description><gtr:id>F7D51766-8FA7-4C32-8C86-EB768A1AB6EE</gtr:id><gtr:impact>One publication so far:
1: Thomson JP, Fawkes A, Ottaviano R, Hunter JM, Shukla R, Mjoseng HK, Clark R, Coutts A, Murphy L, Meehan RR. DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signatures. Sci Rep. 2015 May 14;5:9778.

Five or more in preparation</gtr:impact><gtr:outcomeId>56d98947a540b8.27113601</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DNA immunoprecipitation semiconductor sequencing; &quot;DIP-SC-seq&quot;</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.nature.com/articles/srep09778</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7D261598-02E6-4D57-9C16-FB6AF3FABE4A</gtr:id><gtr:title>Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c630813f93fdb99dbc8547a16fc211e7"><gtr:id>c630813f93fdb99dbc8547a16fc211e7</gtr:id><gtr:otherNames>Luisier R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn><gtr:outcomeId>542e75a4d351e3.95022522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C345860-4D82-4641-8FA9-2769DBA905C2</gtr:id><gtr:title>Defending the genome from the enemy within: mechanisms of retrotransposon suppression in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4acc8eba6022a30ee04f0e79be1fb53"><gtr:id>b4acc8eba6022a30ee04f0e79be1fb53</gtr:id><gtr:otherNames>Crichton JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>pm_14263_23_24045705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95FB77DE-CC95-4525-89BF-CA2CB573CA62</gtr:id><gtr:title>The genome-defence gene Tex19.1 suppresses LINE-1 retrotransposons in the placenta and prevents intra-uterine growth retardation in mice.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6320490484abba0201d62fb40ea013cd"><gtr:id>6320490484abba0201d62fb40ea013cd</gtr:id><gtr:otherNames>Reichmann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>Qdn8CmSg1W1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39F6A463-CECE-4D4F-84F7-466024A3BEE4</gtr:id><gtr:title>The application of genome-wide 5-hydroxymethylcytosine studies in cancer research.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>58a1a0825261e7.99661549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA9B97B8-3C02-4346-B774-F230B96D09C3</gtr:id><gtr:title>LINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events?</gtr:title><gtr:parentPublicationTitle>Mobile genetic elements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4780f2bfc3988e5052d46989d75ca0a"><gtr:id>d4780f2bfc3988e5052d46989d75ca0a</gtr:id><gtr:otherNames>Tufarelli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2159-2543</gtr:issn><gtr:outcomeId>542e75a3d57ef8.76468849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9BD4B72-B47A-4F18-B5FC-AFBE9C0D5EDB</gtr:id><gtr:title>5-Hydroxymethylcytosine Remodeling Precedes Lineage Specification during Differentiation of Human CD4(+) T Cells.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>582994ebcbdd81.70849341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D92976B8-FEAF-47F1-8F9F-419218E284F7</gtr:id><gtr:title>Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/beef200c9252b10229a52a6fd2b95d12"><gtr:id>beef200c9252b10229a52a6fd2b95d12</gtr:id><gtr:otherNames>Hackett JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>pm_14263_23_22949617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDE583A5-6A12-42AF-8692-8C3248137728</gtr:id><gtr:title>An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c6a07e95c767d5396f3151e0611dfd0"><gtr:id>2c6a07e95c767d5396f3151e0611dfd0</gtr:id><gtr:otherNames>Drake AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>pm_14263_23_22642564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC4A6C08-B7A5-48CA-8FE7-635897EFD531</gtr:id><gtr:title>Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.</gtr:title><gtr:parentPublicationTitle>Science immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59e42e9d22616597037c27e2e8b3dbf"><gtr:id>a59e42e9d22616597037c27e2e8b3dbf</gtr:id><gtr:otherNames>Thompson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2470-9468</gtr:issn><gtr:outcomeId>58c6858e5f3fa2.50321828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31186A07-A05C-48C9-97E5-8C7004F5576F</gtr:id><gtr:title>Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>569fa69c4b6879.66537634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF212AE9-2254-45E7-980A-210E0C8F7350</gtr:id><gtr:title>From paramutation to paradigm.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cda3bf0cd53483e22837e1a4c48967cd"><gtr:id>cda3bf0cd53483e22837e1a4c48967cd</gtr:id><gtr:otherNames>Adams IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_14263_23_23717216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18209C56-8611-4BB0-8DA4-F9489D88D20B</gtr:id><gtr:title>Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf55d394709d413ae75cfa527101077"><gtr:id>daf55d394709d413ae75cfa527101077</gtr:id><gtr:otherNames>Cole JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5994431958b646.43130563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4A3C61A-B861-4363-99B4-94BAFE4D1123</gtr:id><gtr:title>Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4e76615cc778430bf81c2ff45fd04cb"><gtr:id>b4e76615cc778430bf81c2ff45fd04cb</gtr:id><gtr:otherNames>McPherson RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56d97a1f597dc4.19476891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3820D9A-4040-4565-9E44-46DF57DFA5C0</gtr:id><gtr:title>Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98548b7f0d172a12eb55f6751ffbd86e"><gtr:id>98548b7f0d172a12eb55f6751ffbd86e</gtr:id><gtr:otherNames>Cruickshanks HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_14263_23_23703216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F87E53-628F-4106-A8FE-3CA9CDD9BE76</gtr:id><gtr:title>Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d3da3f0e8e527d9336211feeacb425b"><gtr:id>8d3da3f0e8e527d9336211feeacb425b</gtr:id><gtr:otherNames>Lempi?inen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn><gtr:outcomeId>pm_14263_23_23091169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00436165-EBCA-4C92-AC84-75D8A5C58762</gtr:id><gtr:title>Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_14263_23_23598998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3F2C73-DEB6-48EB-BD56-B92F0E0D33A2</gtr:id><gtr:title>Investigating 5-hydroxymethylcytosine (5hmC): the state of the art.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14263_23_24162993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28A534B7-884C-47E3-A423-9641E2284D25</gtr:id><gtr:title>5-Hydroxymethylcytosine Profiling in Human DNA.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56d9791ddbed37.11333138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98285CE0-C0E6-4CB2-9912-EED15AAAC56D</gtr:id><gtr:title>Targeting of Rac GTPases blocks the spread of intact human breast cancer.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89294f6bf27bc4dafad391db6a16756e"><gtr:id>89294f6bf27bc4dafad391db6a16756e</gtr:id><gtr:otherNames>Katz E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>pm_14263_23_22689141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57CE1B19-0851-4A06-815F-E6DDE2986DC0</gtr:id><gtr:title>Epigenetic profiles as defined signatures of xenobiotic exposure.</gtr:title><gtr:parentPublicationTitle>Mutation research. Genetic toxicology and environmental mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1383-5718</gtr:issn><gtr:outcomeId>pm_14263_23_24001620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02605C9C-F714-4D88-A1C1-C49DFC5CD50E</gtr:id><gtr:title>Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop.</gtr:title><gtr:parentPublicationTitle>Regulatory toxicology and pharmacology : RTP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a98a522ec89861753fe4b33e0cbcdcc"><gtr:id>9a98a522ec89861753fe4b33e0cbcdcc</gtr:id><gtr:otherNames>Buesen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0273-2300</gtr:issn><gtr:outcomeId>5a9d6da1ce3073.31973330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6562BD03-2C6F-40D7-AA17-0E325CBAF923</gtr:id><gtr:title>Genomic insights into cancer-associated aberrant CpG island hypermethylation.</gtr:title><gtr:parentPublicationTitle>Briefings in functional genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2294dad92431bb8ee1ed5446506e3520"><gtr:id>2294dad92431bb8ee1ed5446506e3520</gtr:id><gtr:otherNames>Sproul D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-2649</gtr:issn><gtr:outcomeId>56d97acbf2da96.96073473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33AE0F97-2CD2-4585-9045-707D84A77173</gtr:id><gtr:title>Microarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6320490484abba0201d62fb40ea013cd"><gtr:id>6320490484abba0201d62fb40ea013cd</gtr:id><gtr:otherNames>Reichmann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>pm_14263_23_22570599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA6793B2-4A42-4FD9-A84B-083C8B592CBC</gtr:id><gtr:title>MBD4 interacts with and recruits USP7 to heterochromatic foci.</gtr:title><gtr:parentPublicationTitle>Journal of cellular biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeed92cffe6e84d4d4f20c649670257b"><gtr:id>eeed92cffe6e84d4d4f20c649670257b</gtr:id><gtr:otherNames>Meng H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0730-2312</gtr:issn><gtr:outcomeId>569fa5309105d6.24414858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40075C2C-75EA-469F-BAF3-B8BF51B05B5F</gtr:id><gtr:title>Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>UgLVya4eiy8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DCF131F-8796-409F-9D99-A013F662E407</gtr:id><gtr:title>Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/555f364f1669660a13643bcc796b03cc"><gtr:id>555f364f1669660a13643bcc796b03cc</gtr:id><gtr:otherNames>Raven A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a27cff90d6706.86332737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3317E49F-5656-4129-A06F-98D8A53D6684</gtr:id><gtr:title>Defining baseline epigenetic landscapes in the rat liver.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>5a27cd33121433.77864025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BE14E7D-7639-4B5B-89C6-E855683C124B</gtr:id><gtr:title>Methyl donor deficient diets cause distinct alterations in lipid metabolism but are poorly representative of human NAFLD</gtr:title><gtr:parentPublicationTitle>Wellcome Open Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20e5b135f9d83b4876de9d2136631df3"><gtr:id>20e5b135f9d83b4876de9d2136631df3</gtr:id><gtr:otherNames>Lyall M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a27cf3ea3fc42.64932815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82805832-1276-42F2-AAD1-F231A61783F7</gtr:id><gtr:title>Deep C diving: mapping the low-abundance modifications of the DNA demethylation pathway.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23732041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D28F8BDE-5B52-4934-913E-AD5A19E806D5</gtr:id><gtr:title>Non-canonical functions of the DNA methylome in gene regulation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>XuCRpkJG6hd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48924F42-79EE-4651-A487-6A643C4EFA80</gtr:id><gtr:title>Importance of investigating epigenetic alterations for industry and regulators: An appraisal of current efforts by the Health and Environmental Sciences Institute.</gtr:title><gtr:parentPublicationTitle>Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89be9028229b48dc5bd6fcdd18ca8d28"><gtr:id>89be9028229b48dc5bd6fcdd18ca8d28</gtr:id><gtr:otherNames>Miousse IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-483X</gtr:issn><gtr:outcomeId>569fa7697d5a79.13765379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCCFD6A9-E74C-477D-8EF8-0FA8DBD6E4FF</gtr:id><gtr:title>Modules, networks and systems medicine for understanding disease and aiding diagnosis.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e44b1707d6d55e92fe6a041aa60ee6b"><gtr:id>0e44b1707d6d55e92fe6a041aa60ee6b</gtr:id><gtr:otherNames>Gustafsson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>569fa44f012938.37703856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9661E28-7C59-4FF9-9296-851C6C2AE9F0</gtr:id><gtr:title>Epigenetic reprogramming: preparing the epigenome for the next generation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40aa54e885d16be28d229d4d79a26d0"><gtr:id>f40aa54e885d16be28d229d4d79a26d0</gtr:id><gtr:otherNames>Rose CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_14263_23_23697942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A065016-A504-4E94-8D9F-9407A20536DB</gtr:id><gtr:title>Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23531360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEA08B54-FDFF-4C9E-8277-6E962A0A62B1</gtr:id><gtr:title>Hydroxymethylated DNA immunoprecipitation (hmeDIP).</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8325dbf499f9df455860713307706458"><gtr:id>8325dbf499f9df455860713307706458</gtr:id><gtr:otherNames>Nestor CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14263_23_24162994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E1FE310-8708-45AD-9444-155D72522D99</gtr:id><gtr:title>SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977df90660e78bb470906ca51984d8c9"><gtr:id>977df90660e78bb470906ca51984d8c9</gtr:id><gtr:otherNames>Shaw ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58a1a1ce0bed71.42422294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BED5D206-E39A-4D6B-9610-9C29709B77A2</gtr:id><gtr:title>The CXXC-TET bridge--mind the methylation gap!</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>pm_14263_23_23711677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C113D0-3483-4C93-83F5-C8B1FDABDE08</gtr:id><gtr:title>Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23034186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D00B5A-F5B7-47AF-B22F-B56F5D7C216E</gtr:id><gtr:title>DNA methylation reprogramming in cancer: does it act by re-configuring the binding landscape of Polycomb repressive complexes?</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385830da8e668f868ad41509c80b3eb9"><gtr:id>385830da8e668f868ad41509c80b3eb9</gtr:id><gtr:otherNames>Reddington JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>542e75a4403542.53631549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA42D806-1DA0-4B30-ABCA-507B699D8222</gtr:id><gtr:title>DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signatures.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>569fa71cd8af53.82402860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF528A0F-FD30-4342-9351-815C90C29083</gtr:id><gtr:title>Senescent cells harbour features of the cancer epigenome.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98548b7f0d172a12eb55f6751ffbd86e"><gtr:id>98548b7f0d172a12eb55f6751ffbd86e</gtr:id><gtr:otherNames>Cruickshanks HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>542e75a4123687.45712123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8946F17F-8227-44F4-B3F7-3950506DC260</gtr:id><gtr:title>Mobilization of LINE-1 retrotransposons is restricted byin mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10fdfb376e6a8d9f9e17e0768221efd"><gtr:id>c10fdfb376e6a8d9f9e17e0768221efd</gtr:id><gtr:otherNames>MacLennan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>59944632f1e892.07522913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88464D56-D68F-4411-9E5E-E024C9392014</gtr:id><gtr:title>Lsh Is Essential for Maintaining Global DNA Methylation Levels in Amphibia and Fish and Interacts Directly with Dnmt1.</gtr:title><gtr:parentPublicationTitle>BioMed research international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>569fa829bce982.88703160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE1B0F4D-609E-495D-8CFC-A6D94ED25126</gtr:id><gtr:title>Decoupling of DNA methylation and activity of intergenic LINE-1 promoters in colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74aac2db8bf1790a5050df2af1e7fcac"><gtr:id>74aac2db8bf1790a5050df2af1e7fcac</gtr:id><gtr:otherNames>Vafadar-Isfahani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>599440fc5251f6.32536298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D28FA3E7-4F0E-4259-BC31-F0A37D0A99A6</gtr:id><gtr:title>Shoring up DNA methylation and H3K27me3 domain demarcation at developmental genes.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2ae7877a3696bf09c49c61736a9a1c1"><gtr:id>b2ae7877a3696bf09c49c61736a9a1c1</gtr:id><gtr:otherNames>Meehan RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a54d12d98eab0.77907284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF0FEC26-F39D-4067-8C75-1571671703FC</gtr:id><gtr:title>Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3567b7f993a8e708d57d22a4ceba8175"><gtr:id>3567b7f993a8e708d57d22a4ceba8175</gtr:id><gtr:otherNames>Thomson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>582996b0859f36.63102904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D467CD5E-AA1C-41FE-9B7F-FD19CB990D05</gtr:id><gtr:title>Dynamic changes in DNA modification states during late gestation male germ line development in the rat.</gtr:title><gtr:parentPublicationTitle>Epigenetics &amp; chromatin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40aa54e885d16be28d229d4d79a26d0"><gtr:id>f40aa54e885d16be28d229d4d79a26d0</gtr:id><gtr:otherNames>Rose CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-8935</gtr:issn><gtr:outcomeId>542e75a509a9e5.58209082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3229FA8-B131-4AAC-BCBE-A7B8CC29AFFE</gtr:id><gtr:title>5-hydroxymethylcytosine profiling as an indicator of cellular state.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34f346386c513bb4933b76fee2a584d9"><gtr:id>34f346386c513bb4933b76fee2a584d9</gtr:id><gtr:otherNames>Laird A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>tfbDHjNyjhR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51371DC4-6CA8-4E5C-9DEF-006E4AFD80B4</gtr:id><gtr:title>Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2294dad92431bb8ee1ed5446506e3520"><gtr:id>2294dad92431bb8ee1ed5446506e3520</gtr:id><gtr:otherNames>Sproul D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_14263_23_23034185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D3AF4D0-E9FE-4F9A-8211-1DADB8A23680</gtr:id><gtr:title>Lsh regulates LTR retrotransposon repression independently of Dnmt3b function.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b948bbf8fb5cbdccfe5e4b4d6ad63b52"><gtr:id>b948bbf8fb5cbdccfe5e4b4d6ad63b52</gtr:id><gtr:otherNames>Dunican DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>542e75a4a5c570.64978290</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_U127574433</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>